Mauna Kea Technologies SA (FRA:1MK)

Market Cap	15.33M +31.5%
Revenue (ttm)	8.18M +0.3%
Net Income	-10.39M
EPS	-0.14
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	250
Open	0.1570
Previous Close	0.1680
Day's Range	0.1570 - 0.1570
52-Week Range	0.0423 - 0.2050
Beta	n/a
RSI	47.98
Earnings Date	Apr 22, 2026

About Mauna Kea Technologies

Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate reactions as they occur, classify areas of uncertainty, guide surgical interventions, and help diagnose and treat patients. The company was incorporat...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 61
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1MK

Financial Performance

In 2024, Mauna Kea Technologies's revenue was 8.42 million, a decrease of -23.69% compared to the previous year's 11.03 million. Losses were -10.40 million, 179.2% more than in 2023.